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Abstract
Implementing clinical trials with large multicenter
samples is an important way to scientifically evalu-
ate and demonstrate the curative effect of moxibus-
tion. At present, clinical trials on moxibustion with
large multicenter samples are prospering in China.
It is necessary for research units to have good re-
search professionals and technical platforms as
well as a highly standardized and scientifically feasi-
ble methodology of research. Taking tasks in the
ongoing national 973 project and in the sci-tech
support program of the "11th 5-year plan", for ex-
ample, this research captures the characteristics of
moxibustion, carries out deep analysis and intro-
duces specific methods and the important signifi-
cance of clinical research tasks on moxibustion in
designing multicenter plans, implementing experi-
ments, supervising quality and strengthening com-
pliance.
© 2012 JTCM. All rights reserved.
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INTRODUCTION
Scientifically evaluating and demonstrating the cura-
tive effect of moxibustion is the only way to realize its
inheritance and creation and an important method for
clinically explaining the scientific rationale of "when
acupuncture does not work, moxibustion is appropri-
ate". At present, because multicenter clinical trials on
moxibustion with large samples in China are at their
initial stage, it is necessary to steadily re-examine and
perfect study design concepts and the implementation
of details. On the one hand, designing clinical trials
with high quality is important for scientifically verify-
ing the curative effect of moxibustion. On the other
hand, differing from traditional medicinal treatment,
moxibustion has its own characteristics in discipline
and clinical practice. Research units should follow the
characteristics of moxibustion and work out suitable re-
search plans without violating the basic principles of
clinical trials. Therefore, a project of "research into
treatment planning and evaluation of acupuncture and
moxibustion" is specially set up in the national sci-tech
support program of the "11th 5-year plan" to guide
the design of a clinical research plan that both con-
forms to the characteristics of acupuncture and moxi-
bustion and is acceptable to the academic cycle [1,2]. The
hospital affiliated with the Jiangxi Traditional Chinese
Medicine (TCM) College is taking the lead in imple-
menting the research into an optimized plan for treat-
ment of chronic persistent asthma with heat-sensitive
moxibustion. This is the only multicenter clinical trial
in the project group to evaluate the curative effect of
moxibustion, which has been registered as ChiC-
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TR-TRC-09000599 at China's clinical trial registra-
tion center. Taking this project as an example, this arti-
cle outlines the characteristics of moxibustion, carries
out deep analysis and introduces specific methods for
multicenter clinical research tasks on moxibustion in-
cluding designing plans, implementing trials, supervis-
ing quality and strengthening compliance. This study
was approved by the appropriate ethics committees
and was performed in accordance with the ethical stan-
dards laid down in the Declaration of Helsinki. All per-
sons signed their informed consent prior to their inclu-
sion in the study.
FOLLOWINGTHE CHARACTERISTICS
OFTRIAL DESIGN ANDDISPLAYING
THE CURATIVE EFFECT OFMOXI
BUSTION IN CLINICAL PRACTICE
Central randomized system
The optimized plan for treatment of chronic persistent
asthma with heat-sensitive moxibustion is through mul-
ticenter clinical trials carried out by 12 units with large
samples and a central randomized system. The China
Academy of Chinese Medical Sciences is undertaking
the central randomization and realizing data manage-
ment.
Blinding of evaluators
The details of the clinical research plan and the restric-
tion of manipulation in moxibustion present challeng-
es for blinding. The blinding of evaluators used in the
optimized plan on treatment of chronic persistent asth-
ma with heat-sensitive moxibustion is accomplished by
using evaluators who do not know the grouping condi-
tion when they evaluate patients.
Control group of positive drug
In the optimized plan on treatment of chronic persis-
tent asthma with heat-sensitive moxibustion, it was not
possible to select sham moxibustion as the control
group, as only using a negative or ineffective measure
to treat chronic asthma patients does not conform to
ethical requirements. Therefore, the task group is using
Shulida, an internationally accepted drug to control
asthma, for the control group. According to the global
proposal on preventing and treating asthma (GINA
2002), inhaled glucocorticoid hormone combined with
a long acting β2 receptor agonist is used as the initial
plan for preventing and treating asthma. Shulida is con-
firmed as a standard drug with definite curative effects.
It is a feasible control method in consideration of eth-
ics, clinical practice and methodology.
Repeatability
Comparative research is generally divided into 3 types:
superiority, non-inferiority and equivalence[3]. Previous
researches carried out by the task group showed that
heat-sensitive moxibustion may be similar to Shulida
in curative effect. Acupuncture and moxibustion take
effect on the basis of regulating the whole body. Start-
ing from clinical design, it is impossible for acupunc-
ture and moxibustion to be superior to target-regulat-
ing drugs in curative effect. However, acupuncture and
moxibustion have the superiority of regulating the
whole body. Therefore, a non-inferiority experimental
design is more suitable for objectively evaluating the cu-
rative effect of acupuncture and moxibustion.
In the optimized plan on treatment of chronic persis-
tent asthma with heat-sensitive moxibustion, the sam-
ple size is estimated with the following formula involv-
ing 4 factors: the average effective rate P, the active
comparator effect mean, the experimental treatment ef-
fect mean and the non-inferiority critical value δ.
n = 2 × ( )Uα +Uβ
2
δ2 ×P(1 -P)
In the formula, α=0.05 and β=0.2. The average effec
tive rate P is based on the data from clinical experi-
ments of the International Asthma Alliance (GOAL).
The asthma-controlling rate of Shulida can reach 71%.
Selecting δ is of vital importance[4]. If too large a δ is se-
lected, drugs with inadequate medicinal effect are
judged as non-inferior. If too small a δ is selected, the
clinical value of drugs may be underestimated. This val-
ue should not be larger than the effective difference Δ
of the effect confirmed by optimum effective experi-
ments with a placebo control group. Therefore, the
task group is selecting δ =0.15. The calculations indi-
cate that each group needs 120 cases and the two
groups need 240 cases in all. If the missed visit rate is
controlled at 20%, the total sample required is about
288 cases. In addition, it is necessary to point out that
statistical deduction in non-inferiority experiments is
different from traditional methods.
Superiority in curative effect of moxibustion
In its previous trials, the task group discovered that the
treatment of chronic persistent asthma with heat-sensi-
tive moxibustion can not only improve symptoms but
also decrease complications such as oppressed feeling in
the chest, reduce relapse rate and enhance patient quali-
ty of life. Therefore, when designing indices for measur-
ing during trials, the task group selected a series of indi-
ces which can reflect the improvement of the quality of
life of asthma patients. For example, the international-
ly used score for evaluating asthma control, the Asthma
Control Test™ (ACT), is used to comprehensively test
daily ability to function normally, level of asthma
symptoms, frequency of rescue drug use and level of
asthma control.
IMPLEMENTINGTHE CONCEPT OF
OPTIMIZED PLAN AND ENHANCING
TOP LEVEL OF DESIGN
Optimization, a concept of top design, requires re-
searchers to repeatedly revise their plan in order to
make it more strict, scientific and rational[5,6]. In the
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above-mentioned characteristics of experimental de-
sign, central randomization, blinding of evaluators,
set-up of control and estimation of sample size are the
result of the optimization of plan.
Mode of experimental design
In the initial plan of the task group, two factors of ther-
apeutic dosage (A) and manipulator (B) and two levels
of 60 minute dosage (A1) and disappearance of
heat-sensitive phenomenon (A2) as well as doctor (B1)
and subject (B2) were used in the experimental group.
Shulida was used in the control group. Through discus-
sion, the experts agreed that it is very difficult to make
manipulations on subjects identical, as there are many
uncontrollable factors, and that this method should be
simplified. Therefore, the mode of design was simpli-
fied into a parallel comparison between two groups,
with heat-sensitive moxibustion used in the experimen-
tal group.
Defining the target population
Included in the trial are patients who have the heat-sen-
sitive phenomenon at the corresponding site and who
can correctly express the sensation of moxibustion and
coordinate their behavior. This creates the sensation of
moxibustion, a nice warm feeling around the area. The
following patients sensation suggested the heat-sensi-
tive phenomenon: diathermanous sensation due to
moxa-heat, defining as the heat sensation conducting
from the moxa local skin surface into deep tissue, or
even into the joint cavity; expand heat sensation due to
moxa-heat, defining as the heat sensation spreading the
surrounding little by little around the moxa point;
transfer heat sensation due to moxa-heat, defining as
the heat sensation transferring along some pathway or
direction; non-heat sensation due to moxa-heat. Ex-
cluded are those who cannot tolerate the smoke of
moxibustion on the basis of their level of complica-
tions and severity of disease.
Setting up the treatment course
The task group has put forward a method of treatment
management in sections. Patients are treated once daily
for 8 days from their first visit; 12 treatments are guar-
anteed in the last 22 days of the first month; and 15
treatments are guaranteed every month in the next 2
months (≤once every day). This enhances convenience
for subjects who can flexibly arrange the time of treat-
ments. The treatment course covers 3 months in the
two groups based on the conventional treatment
course using Shulida.
Optimized indexes for observation
When optimizing the plan, the experts unanimously
agreed that internationally used quantified indices
should be used as much as possible, and that objective
indices which can embody the superiority of moxibus-
tion should be used as supplements at the same time.
Therefore, the task group is using the scores for evaluat-
ing asthma control (ACT), determinations of pulmo-
nary function, and the scores for evaluating TCM
symptoms to judge the curative effect of interventional
measures in clinical practice.
ESTABLISHING A SYSTEMOF SCIE-
NTIFIC SUPERVISION AND STAN-
DARDIZINGTHEMANAGEMENT OF
CLINICALTRIALS
According to the standards of clinical research in acu-
puncture and moxibustion, clinical epidemiology, evi-
dence-based medicine, GCP clinical research methods,
requirements of international clinical experiments and
the TCM standard of quality control and quality guar-
antee in clinical researches of China, a 3-level quality
check system is being established[7,8].
Appointing supervisors and identifying their
qualifications
Because the whole project will involve research at 12
centers, supervisors directly appointed by the quality
supervision committee of the project will be responsi-
ble to the project office. Multicenter moxibustion trials
are characterized by large samples and a long period of
observation. Supervisors should have comprehensive
knowledge and a professional background[9,10]. Quality
inspectors are appointed by the responsible person at
each center and trained by the task group before task
implementation.
Drawing up the plan and procedure of supervision
The supervision plan consists of the following: 1) the
number of supervisors is planned according to the
number of units undertaking the task [11]; 2) the num-
ber of visits by supervisors is planned according to the
clinical experimental plan and research speed; 3) the
frequency of visits is regulated according to the prog-
ress and quality of the research.
Common problems and their management
Data in the case report platform (CRP)table carry the
contents of the clinical trial. Supervisors have found
that many research units inconsistently express onset
frequency as 8 times per month or twice per week, and
pulmonary function as absolute value or percentage or
both. Therefore, the task group contacts the responsi-
ble persons at the centers as needed to fill in the table
consistently.
Accurately locating the application point for heat-sensi-
tive moxibustion is a key factor for enhancing its cura-
tive effect [13,14]. At the pre-test stage of the clinical ex-
periment, having discovered that individual researchers
at some centers were not skilled in accurately locating
the application point for heat-sensitive moxibustion,
the task group assigned supervisors to carry out
on-the-spot or online instruction as needed.
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The sensation-eliminating dose is the key to realizing
the individual moxibustion dose in heat-sensation mox-
ibustion[15]. At the pre-test stage of the clinical experi-
ment, the task group discovered that when treating pa-
tients with heat-sensation moxibustion, individual re-
searchers at some centers had not given enough moxi-
bustion dosage. The time (30-90 min) of each treat-
ment must make the heat-sensation phenomenon dis-
appear at the point of moxibustion[16]. On-the-spot or
online detailed explanations of the importance of giv-
ing enough moxibustion dosage enables researchers at
the centers to appreciate its importance in order to
achieve the best curative effect of heat-sensation moxi-
bustion.
ENHNCING COMPLIANCE OF
SUBJECTS AND STRENGTHENING
CONFIDENCE INTHE
EXPERIMENTAL RESULT
Good compliance of subjects is the key to guaranteeing
the quality of clinical trials[17]. In clinical multicenter
trials of moxibustion , a broad source for the included
population, the characteristics of the interventional
measures and a long period of observation make the
compliance of subjects different from their compliance
in general clinical trials.
Course of treatment intervention
Research shows that the compliance of patients is nega-
tively correlated with the complexity of the interven-
tional plan (such as the times, dosage and frequency of
medication) [18]. Combined use of many drugs will re-
duce the compliance of patients. The longer the thera-
peutic time is, the poorer the compliance will be[19,20].
In the project, both the heat-sensation moxibustion
and Shulida used in the two groups are interventional
methods, particularly the Shulida used in the control
group[21]. Shulida, a mixed dosage form of salmeterol
and fluticasone propionate, as a powder inhalant, con-
forms to the interventional requirements of a com-
pound drug for patients with chronic asthma and is
convenient for subjects to use[22,23]. The two groups
were treated for 3 months. In consideration of the char-
acteristics of moxibustion, subjects should generally go
to research units for treatment. Too frequent moxibus-
tion treatments will inevitably influence the work or
study of subjects and reduce compliance. Therefore,
the task group used a method of management in sec-
tions. Subjects were treated for 8 days in a row from
their first visit, once every day; 12 treatments were
guaranteed in the last 22 days of the first month; and
15 treatments were guaranteed every month in the
next two months (≤ once every day).
Safety of moxibustion and adverse drug reactions
Although moxibustion is a green therapy without trau-
ma, appropriate measures should be taken before treat-
ment to guarantee the safety of moxibustion. Before
moxibustion, the physician should put the subject in a
calm environment and pay close attention to the burn-
ing condition of the moxa roll in order to avoid scald-
ing.
Effectively measuring compliance
The interventional plan of the project consists of two
completely different types of therapeutic measures:
heat-sensation moxibustion and inhalant medication.
The task group used different methods to evaluate sub-
jects in the two groups. In the experimental group,
moxibustion dosages were collected from physicians
and subjects and their original data were checked at
moxa-roll distribution centers to calculate the compli-
ance of subjects. In the control group, researchers calcu-
lated the rate of medication use by subjects according
to the surplus drug in the inhaler[24,25].
CREATING A GOOD PHYSICIAN-
PATIENT ENVIRONMENT
In the project, because of the long period of observa-
tion, it is very difficult for some patients to persist in
treatment once their symptoms have been improved.
Therefore, it is necessary to establish a communication
channel. All the researchers have a card for contact
with subjects, on which the name, telephone number
and address of the subjects are recorded. Researchers
encourage patients to write a medication diary. A be-
nign system for feeding back information among physi-
cians, nurses and subjects is formed to make subjects
feel safe and at ease during the process of the trials
without dropout of cases due to the long periods be-
tween follow-up visits.
SUMMARY
Understanding the characteristics of research design
and implementing progressive optimization of the re-
search plan are two trends in the methodology of clini-
cal research into acupuncture and moxibustion at pres-
ent. We have earnestly sorted out, summed up and ex-
tracted the results of previous researches and the condi-
tions of clinical practice, formed a preliminary clinical
treatment plan according to the aims and demands of
this research, reached consensus after full discussion by
experts in the task group and participating units, ab-
sorbed proposals from well-known experts in method-
ology, statistics and clinical practice in reference to the
latest research achievements at home and abroad, and
optimized and perfected the experimental plan.
In order to guarantee the quality of the research task
and the reliability of the research results, researchers
must implement scientific and rational quality supervi-
sion. Although relevant standards for managing clinical
trialss can be used for reference, it is necessary for re-
searchers to constantly re-examine the moxibustion tri-
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al because of its unique characteristics. The project is a
beneficial exploration to constantly perfect and opti-
mize the supervision plan from application for the
task, through proof by experts, to implementation of
the task in order to strive to absolutely guarantee the re-
liability of the research results.
In addition, multicenter clinical trials on moxibustion
aim at objectively and accurately evaluating the cura-
tive effect and safety of moxibustion. It is necessary for
designers to consider if moxibustion and non-moxibus-
tion are correctly implemented in order to reduce the
dropout rate and enhance the compliance of subjects.
In short, in implementing multicenter clinical random-
ized controlled trials on moxibustion with high quality
and large samples, it is necessary for research units to
have good researchers, adequate technical platforms
and a highly standardized, scientific and feasible meth-
odology of research. The task group believes that scien-
tifically designing the plan, optimizing the contents of
plan, supervising quality and strengthening compliance
are the key links.
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